HCWB
HCW Biologics Inc.
NASDAQ · USHealthcareBiotechnology
$3.83-4.25%
Price as of Jul 20, 2026
HCWB financials
HCW Biologics Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $54.2K | $2.6M | $2.8M | $6.7M |
| Cost of revenue | $43.4K | $1.6M | $2.3M | $4.1M |
| Gross profit | $10.8K | $959.4K | $560.4K | $2.6M |
| Operating expenses | $11.3M | $30.4M | $26.3M | $17.7M |
| Operating income | -$11.3M | -$29.5M | -$25.7M | -$15.1M |
| Net income | -$8.0M | -$30.0M | -$25.0M | -$14.9M |
| EBITDA | -$5.7M | -$27.7M | -$23.6M | -$14.1M |
| Basic EPS | $-63.78 | $-4.62 | $-4.20 | $-2.52 |
| Diluted EPS | $-63.78 | $-4.62 | $-4.20 | $-2.52 |
| Balance sheet | ||||
| Cash & equivalents | $2.0M | $4.7M | $3.6M | $22.3M |
| Total assets | $24.5M | $30.2M | $28.5M | $46.8M |
| Total liabilities | $21.8M | $37.0M | $15.1M | $9.4M |
| Stockholders’ equity | $2.8M | -$6.8M | $13.5M | $37.4M |
| Total debt | $6.8M | $13.7M | $6.3M | $6.4M |
| Net debt | $4.9M | $9.0M | $2.7M | -$15.9M |
| Cash flow | ||||
| Operating cash flow | -$13.4M | -$14.2M | -$22.5M | -$10.4M |
| Capital expenditure | -$3.00 | -$261.6K | -$6.2M | -$10.3M |
| Free cash flow | -$13.4M | -$14.5M | -$28.7M | -$20.7M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |